Potential value of cefoperazone in bacterial meningitis: experimental studies
Related Experiment Videos
Abstract:
To assess the potential value of cefoperazone in treating bacterial meningitis, its pharmacokinetics in the cerebrospinal fluid of rabbits were studied. Cefoperazone penetrated poorly into the cerebrospinal fluid of rabbits with uninflamed meninges, but in the presence of meningitis concentrations increased 2- to 3-fold. These concentrations were above the minimum inhibitory concentrations for the majority of Enterobacteriaceae, indicating the potential value of cefoperazone in treating bacterial meningitis. The half-lives of cefoperazone and moxalactam in cerebrospinal fluid, measured by a bioassay, were marked prolonged by meningeal inflammation. In contrast, the half-life of cefotaxime in cerebrospinal fluid was short. Consequently both cefoperazone and moxalactam provided significantly better antibacterial effect in cerebrospinal fluid than did cefotaxime.
Insights
Cefoperazone shows potential for treating bacterial meningitis by reaching effective cerebrospinal fluid concentrations, especially during inflammation. Its prolonged half-life in cerebrospinal fluid offers a better antibacterial effect compared to cefotaxime.
Area of Science:
- Pharmacology
- Infectious Diseases
- Neuroscience
Background:
- Bacterial meningitis requires effective antibiotic penetration into the cerebrospinal fluid (CSF).
- Understanding antibiotic pharmacokinetics in CSF is crucial for treatment efficacy.
Purpose of the Study:
- To evaluate the pharmacokinetic profile of cefoperazone in rabbit CSF.
- To assess the potential of cefoperazone for treating bacterial meningitis.
Main Methods:
- Pharmacokinetic study of cefoperazone in rabbit CSF.
- Comparison of cefoperazone, moxalactam, and cefotaxime CSF half-lives using bioassay.
- Measurement of drug concentrations in inflamed and uninflamed meninges.
Main Results:
- Cefoperazone CSF penetration was poor in uninflamed meninges but increased 2-3 fold during meningitis.
- CSF concentrations of cefoperazone exceeded MICs for most Enterobacteriaceae.
- Meningeal inflammation prolonged the CSF half-lives of cefoperazone and moxalactam, unlike cefotaxime.
Conclusions:
- Cefoperazone demonstrates potential value in treating bacterial meningitis due to increased CSF concentrations and efficacy.
- Cefoperazone and moxalactam offer superior antibacterial effects in CSF compared to cefotaxime, particularly with inflammation.